
Irl B. Hirsch
Researcher
1
APPEARANCES
1
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
Aug 4, 2026
Practical implementation of inhaled insulin in clinical practice
2:04
2:13
2:39
2:57

David AhnHOST
Can you briefly explain where inhaled insulin fits today within the overall insulin therapy landscape?

Irl HirschGUEST
A lot of people don't appreciate we have had inhaled insulin since 2014, but it's really only been for the last two or three years that I think its popularity has, uh, become prominent, and part of it is simply because we didn't realize when the insulin was approved, we were underdosing the insulin, and this becomes a huge factor.

Irl HirschGUEST
Now, I know in the last few years, automated insulin delivery, especially for Type 1 diabetes, has become, uh, s- the standard of care, and the American Diabetes Association notes this.

Irl HirschGUEST
Not everybody can use AID, and thus, for the multiple daily injection patients, the MDI patients, what is the role of inhaled insulin for that population? And, and I would say that for a huge number of those people, if not most of these people, uh, pulmonary inhaled insulin needs to at least be considered.
23 MINS LATER